Fulgent bought CSI Laboratories, a company focused on cancer diagnostic testing for pathologists, community hospitals and patients. CSI has more than 400 unique tests and capabilities in flow cytometry, cytogenetic analysis, fluorescence in-situ hybridization, immunohistochemistry and molecular genetics.
The acquisition will expand Fulgent’s reach past its current market in Southeastern states. Larry Weiss, MD, Fulgent’s chief medical officer, will oversee the integration of CSI’s capabilities into the Fulgent platform and company operations.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
